CDKN2B and laryngotracheoesophageal cleft: Our study has revealed the potential of CDKN2B-AS1 to be a diagnostic index of LC because of its aberrant expression in peripheral blood and cells of LC cases and has also demonstrated that it is probably a therapeutic target for its regulation of the biological behaviours of LC cells.